Statement
of
Dr. Anna johnson-winegar
Deputy assistant to the secretary of defense for chemical
and biological defense
Biological terrorism
October 17, 2001
Before the
Senate committee on government affairs
First session 107th congress
Mr.
Chairman and distinguished committee members, i am dr. Anna
johnson-winegar, deputy assistant to the secretary of defense for
chemical and biological defense.
My office is the single focal point within the office of
the secretary of defense responsible for oversight, coordination,
and integration of the joint chemical and biological defense
programs.
The tragic events of september 11th and the
recently reported anthrax cases in florida
and elsewhere have heightened the public’s awareness of
the threat posed by biological terrorism.
For some years, the department of defense has considered
the use of biological weapons as a possible means by which states
and non-state actors might counter america’s overwhelming
conventional warfighting strength—often referred to as
asymmetric means. In response to this threat congress directed the
department of defense to consolidate chemical and biological
defense efforts. Since the establishment of a joint chemical and biological
defense program in 1994, and with continued congressional support,
the department of defense has made significant progress in
fielding biological defense equipment for our warfighters and
stands ready to meet the most credible threats.
Biological warfare threats.
In addition, my office stands ready to assist civilian
agencies through technology sharing, technical advice, or as
otherwise requested by the appropriate authorities.
In order to meet the challenge of biological warfare across
the spectrum, our program must address the need for both materiel
improvement and operational concepts to use the new and improved
equipment. In order
to address the issue of bioterrorism, we have documented gaps and
deficiencies in exercises, such as top off, and these will be the
focus of reprioritized efforts within the department of defense.
One of the lessons of the topoff exercise was that to work
effectively during an actual crisis, various governmental agencies
must actually exercise beforehand or their “cultural
differences” will overcome any plan. We will continue to work
with other agencies, including the new office of homeland
security, to ensure good working relationships. One specific area
we will focus on is to help define what support the department of
defense can provide and work with other agencies to define what
support they request and need.
While the dod can provide unique expertise and materiel
support, it is not charged with lead federal agent
responsibilities as described in the federal response plan.
In the area of domestic terrorism medical response, the
department of health and human services takes charge and requests
support as needed. In my testimony today, i will outline the ways the department
of defense provides materiel support to other organizations and
how we coordinate efforts.
Materiel support
Congress has provided a number of statutory methods for
the department of defense to support other federal, state, and
local agencies in preparing for and responding to weapons of mass
destruction (wmd) terrorism.
Requests may come to the department for operational support
or for the purchase of equipment.
These requests are approved on a case-by-case basis.
My office has dealt with a number of requests from
other-federal agencies for individual and collective protective
equipment and access to vaccines, while the operational support
provided by the department is coordinated through the secretary of
the army as the dod executive agent for such matters. The department will continue to provide this support within
statutory and regulatory limits and balance requests against the
readiness of military forces to accomplish their warfighting
mission.
Dod can offer many of its systems, either in the field or
in development, and expertise that may prove useful to civilians.
Dod’s chemical and biological detection equipment could
be applied in civilian situations, as can many of our medical
countermeasures. However,
the provision of materiel alone does not enhance capability, it
needs to be accompanied by valid operational concepts, training,
and maintenance.
The mission of the dod chemical and biological defense
program is to provide materiel to allow our armed forces to be
trained and equipped to conduct their operational missions in
environments contaminated with chemical or biological agents. Our
armed forces are trained primarily for traditional warfighting
requirements. However, our forces also maintain significant
capabilities to support homeland security, through such
operational units as the technical escort unit, the wmd-civil
support teams, and the marine corps’ chemical and biological
incident response force (cbirf).
In order to enhance our nation’s overall capabilities the
department of defense participates in programs to support the
transition of military equipment and concepts to other-than-dod
agencies. Specifically,
The technical support working group (tswg), rapidly
prototypes emerging technologies for high priority federal
interagency requirements (www.tswg.gov);
The interagency board for equipment standardization and
interoperability (known as the iab), is a partnership with
federal, state, and local agencies focused on the capabilities
necessary for fire, medical, and law enforcement responses to wmd
terrorism (www.iab.gov);
The domestic preparedness program, mandated under the 1997
nunn-lugar-domenici legislation, trained and equipped
municipalities to address wmd terrorism (the program transferred
to the department of justice in 2000, reports remain available at
www2.sbccom.army.mil/hld/); and
Interagency agreements with departments of justice’s
office of domestic preparedness to purchase equipment in support
of justice’s grant program.
Medical training programs from the us army medical research
institutes for infectious disease and chemical defense; and
The white house office of science and technology policy
chaired weapons of mass destruction program, research and
development subgroup.
These efforts represent a snap shot of the department’s
procurement and research support to address bioterrorism.
As the lead federal agencies assess their needs, dod
anticipates additional requests of or participation in these
groups.
Coordination
The department of defense has established a set of
requirements for the successful completion of military operations
in chemical and biological environments.
We submit an annual report to congress documenting our
progress in meeting these requirements. My office regularly
coordinates its efforts with the department of energy, department
of health and human services, and the intelligence community
through the counterproliferation program review committee, which
reports annually to congress on its progress (provided as a
classified document to the congress).
Some of the department’s requirements to protect the
military force correlate with civilian requirements to protect the
population against biological terrorism. For instance, one of the
concepts being investigated for the development and production of
biological defense vaccines is a vaccine production facility.
In order to coordinate the needs of the interested
agencies, the dod, relatively early in the process of considering
alternatives for vaccine acquisition, established a federal
interagency advisory group. Participants,
in addition to those from dod agencies, have included
representatives from:
The white house [office of homeland security, office of
science and technology policy, national security council, office
of management and budget],
Federal emergency management agency,
Department of health and human services (dhhs) [national
institutes of health, public health service, food and drug
administration, centers for disease control and prevention, and
the office of the assistant secretary for health and the surgeon
general].
This group, which i chair, has served as a highly effective
and productive forum for discussions concerning u.s. vaccine
acquisition—particularly vaccines for defense against biological
warfare agents—for force health protection and public health
needs for the civilian sector.
Conclusion
Dod works regularly with the lead federal agents to
coordinate requirements and development efforts for biological
terrorism. In
addition to coordination, there are a number of mechanisms for dod
to provide assistance to other-federal, state, and local agencies.
In light of recent events, dod anticipates a greater number
of requests for assistance. Dod
will address these requests on a case-by-case basis to ensure that
public safety is enhanced and dod can still accomplish its
warfighting mission. Thank
you for the opportunity to speak here today, i would be happy to
respond to any questions. Thank
you.
|